本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Candel Therapeutics, Inc.

4.51
-0.0600-1.31%
盘后4.600.0900+2.00%17:57 EDT
成交量:38.53万
成交额:174.93万
市值:2.13亿
市盈率:-2.59
高:4.81
开:4.48
低:4.41
收:4.57
数据加载中...

公司资料

公司名字:
Candel Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2003
员工人数:
38
公司地址:
117 Kendrick Street,Suite 450,Needham,Massachusetts,United States
邮编:
02494
电话:
传真:
- -
简介:
Candel Therapeutics, Inc.于2003年6月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于开发可引发个体化、全身性抗肿瘤免疫反应的现成病毒免疫疗法,以帮助患者对抗癌症。

董事

名称
职位
Paul Peter Tak
Director,President and Chief Executive Officer
Paul B. Manning
Director,chairman of the board
Chris Martell
Director
Diem Nguyen
Director
Edward J. Benz, Jr.
Director
Estuardo Aguilar Cordova
Director
Gary J. Nabel
Director
Joseph C. Papa
Director
Renee Gaeta
Director

股东

名称
职位
Paul Peter Tak
Director,President and Chief Executive Officer
Jason A. Amello
Chief Financial Officer, Treasurer and Secretary
Francesca Barone
Chief Scientific Officer
Seshu Tyagarajan
Chief Technical and Development Officer
W. Garrett Nichols
Chief Medical Officer